Ameritas Investment Partners’s TherapeuticsMD TXMD Stock Holding History

Ameritas Investment Partners’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-549	Closed	-$10K	–	3236
2022 Q1	$10K	Hold	549	–	–	﹤0.01%	2801
2021 Q4	$10K	Hold	549	–	–	﹤0.01%	2906
2021 Q3	$20K	Hold	549	–	–	﹤0.01%	2708
2021 Q2	$33K	Hold	549	–	–	﹤0.01%	2455
2021 Q1	$37K	Buy	549 +169	+44%	+$13.2K	﹤0.01%	2260
2020 Q4	$23K	Hold	380	–	–	﹤0.01%	2410
2020 Q3	$30K	Hold	380	–	–	﹤0.01%	2170
2020 Q2	$24K	Hold	380	–	–	﹤0.01%	2267
2020 Q1	$20K	Hold	380	–	–	﹤0.01%	2191
2019 Q4	$46K	Buy	380 +77	+25%	+$11.1K	﹤0.01%	1972
2019 Q3	$55K	Hold	303	–	–	﹤0.01%	1831
2019 Q2	$39K	Hold	303	–	–	﹤0.01%	2051
2019 Q1	$74K	Hold	303	–	–	﹤0.01%	1670
2018 Q4	$58K	Buy	303 +44	+17%	+$10.7K	﹤0.01%	1715
2018 Q3	$85K	Hold	259	–	–	﹤0.01%	1674
2018 Q2	$81K	Hold	259	–	–	﹤0.01%	1674
2018 Q1	$63K	Hold	259	–	–	﹤0.01%	1782
2017 Q4	$78K	Hold	259	–	–	﹤0.01%	1655
2017 Q3	$77K	Hold	259	–	–	﹤0.01%	1618
2017 Q2	$68K	Hold	259	–	–	﹤0.01%	1704
2017 Q1	$93K	Hold	259	–	–	﹤0.01%	1469
2016 Q4	$75K	Hold	259	–	–	﹤0.01%	1099
2016 Q3	$88K	Buy	259 +31	+14%	+$11.3K	﹤0.01%	1074
2016 Q2	$97K	Hold	228	–	–	0.01%	1003
2016 Q1	$73K	Buy	228 +20	+10%	+$6.82K	﹤0.01%	1006
2015 Q4	$108K	Hold	208	–	–	0.01%	977
2015 Q3	$61K	Hold	208	–	–	﹤0.01%	995
2015 Q2	$82K	Hold	208	–	–	0.01%	1025
2015 Q1	$63K	Buy	+208	New	+$50.8K	﹤0.01%	1079

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Ameritas Investment Partners's TXMD Position: Q2 2022 in Review

Ameritas Investment Partners sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 549 shares — an estimated $10K sold.

Ameritas Investment Partners first reported a position in TXMD in Q1 2015 and held it in 29 quarters. The position peaked at $108K in Q4 2015. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

Ameritas Investment Partners reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 549 TherapeuticsMD shares in Q2 2022, an estimated $10K.
Ameritas Investment Partners first reported a position in TherapeuticsMD in Q1 2015 and held it in 29 quarters.
Ameritas Investment Partners's TherapeuticsMD position peaked at $108K in Q4 2015.
53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.